Wedbush Initiates Coverage On Trulieve Cannabis with Outperform Rating, Announces Price Target of $18

Wedbush analyst Gerald Pascarelli initiates coverage on Trulieve Cannabis (OTC:TCNNF) with a Outperform rating and announces Price Target of $18.


Image
igniteit
December 2, 2022 • 11:30 am
Share: